Search

everythinglearnresearchcommunity

for

Search:↓

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

A Turkish family with sparse hair and eyebrow loss has a mutation in the U2HR gene linked to Marie Unna hereditary hypotrichosis.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Lotion with piroctone olamine and triclosan improves hair loss in men.

Aging causes sweat glands to shrink, leading to skin issues, and blue light can help hair grow.

Hair follicle cells change their DNA packaging during growth cycles and when grown in the lab.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Storing hair follicle micrografts for longer times can cause them to enter a state similar to the natural hair shedding phase, which might impact hair transplant results.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

The paper concludes that detailed patient history, skin exams, and lab tests are crucial for diagnosing and treating hair loss from diffuse alopecia.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Etretinate treatment changed hair growth patterns in many patients.

Botulinum toxin injections may help treat hair loss by blocking harmful secretion in hair follicles.

A gene mutation causes early keratinocyte maturation leading to hair loss in Olmsted syndrome.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Impaired ABCA5 activity disrupts cholesterol balance in hair follicle cells, affecting hair growth.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Boswellia may improve skin inflammation symptoms and positively influence hair growth in mice.

Pdgfα signaling helps maintain fat cells in the skin and is important for hair growth, wound healing, and fighting infections.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

Gamma-ray exposure can cause long-lasting damage to hair follicles, affecting hair structure and color.

Hair is a complex organ, and understanding its detailed structure and growth phases is crucial for analyzing substances within it.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.